• About Us
    • Our Team
    • Transactions
    • Client Videos
  • Raise Capital
  • First Time Investor
    • About EMDs
    • Accredited Investor Qualification
    • KYC Forms
  • News
  • Contact

Khiron Life Sciences A De Facto Beneficiary of Aurora Cannabis – ICC Labs Deal

By Republic SuperStar

Posted: September 11, 2018

Category: News & Events

FSD Pharma Congratulates High Tide Ventures for Selection as Supplier to Ontario Cannabis Retail Corporation
FSD Pharma Issues 40,000,000 Stock Options to Director Dr. Raza Bokhari Conditional on NASDAQ listing
Contact Us
Phone: 647-350-6650
Email: info@firstrepubliccapital.com
55 University Ave Suite 1003
Toronto, Ontario, M5J 2H7
Start the Conversation
Register with your email address and we'll start exploring your options.

  • About Us
    ▼
    • Our Team
    • Transactions
    • Client Videos
  • Raise Capital
  • First Time Investor
    ▼
    • About EMDs
    • Accredited Investor Qualification
    • KYC Forms
  • News
  • Contact